Myriad Genetics
MYGN
#3880
Rank
โ‚ฌ2.31 B
Marketcap
25,53ย โ‚ฌ
Share price
-0.63%
Change (1 day)
57.87%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ0.31 B

According to Myriad Genetics's latest financial reports the company's total liabilities are โ‚ฌ0.31 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.32 B12.66%
2022-12-31โ‚ฌ0.29 B-5.96%
2021-12-31โ‚ฌ0.31 B
2020-06-30โ‚ฌ0.43 B3.96%
2019-06-30โ‚ฌ0.41 B132.73%
2018-06-30โ‚ฌ0.17 B-53.74%
2017-06-30โ‚ฌ0.38 B224.3%
2016-06-30โ‚ฌ0.11 B28.83%
2015-06-30โ‚ฌ92.48 M20.45%
2014-06-30โ‚ฌ76.78 M32.79%
2013-06-30โ‚ฌ57.82 M33.14%
2012-06-30โ‚ฌ43.43 M42.32%
2011-06-30โ‚ฌ30.51 M2.58%
2010-06-30โ‚ฌ29.74 M30.1%
2009-06-30โ‚ฌ22.86 M-51.13%
2008-06-30โ‚ฌ46.79 M78.79%
2007-06-30โ‚ฌ26.17 M23.6%
2006-06-30โ‚ฌ21.17 M9.94%
2005-06-30โ‚ฌ19.26 M54.28%
2004-06-30โ‚ฌ12.48 M-26.15%
2003-06-30โ‚ฌ16.9 M-41.18%
2002-06-30โ‚ฌ28.74 M-25.05%
2001-06-30โ‚ฌ38.34 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ2.62 B 744.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.14 B 910.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.68 M-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.60 B 416.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.19 B 9,608.94%๐Ÿ‡บ๐Ÿ‡ธ USA